Comparative effects of glucose-lowering medications on kidney outcomes in type 2 diabetes: the GRADE randomized clinical trial
Wexler DJ, de Boer IH, Ghosh A, et al.
JAMA Intern Med. 2023;e231487.
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Kidney protection with canagliflozin: a combined analysis of the randomized CANVAS program and CREDENCE trials
Sridhar VS, Neuen BL, Fletcher RA, et al.
Diabetes Obes Metab. Pub. online 15 May 2023.
Leggi
MiniMed 780G advanced hybrid closed loop system outcomes according to pubertal status – awesome study group real-life experience
Rachmiel M, Lebenthal Y, Mazor-Aronovitch K, et al.
Diabetes Technol Ther. Pub. online 23 May 2023.
Leggi
Impact of diabetes mellitus on benefit of β-blocker therapy after myocardial infarction
Zaatari G, Bello D, Blandon C, et al.
Am J Cardiol. 2023;S0002-9149(23)00232-1.
Leggi
Lean nonalcoholic fatty liver disease and risk of incident type 2 diabetes mellitus: a literature review and meta-analysis
Gao Y, Zhao T, Song S, et al.
Diabetes Res Clin Pract. 2023;110699.
Leggi
Age at diagnosis modifies associations of type 2 diabetes with cancer incidence and mortality: a retrospective matched-cohort study
Yang Z, Wu Y , Xu L, et al.
Diabetologia. Pub. online 13 May 2023.
Leggi
Efficacy of empagliflozin in patients with heart failure across kidney risk categories
Butler J, Packer M, Siddiqi TJ, et al.
J Am Coll Cardiol. 2023;81(19):1902–1914.
Leggi
Switching to once-weekly insulin icodec versus once-daily insulin degludec in individuals with basal insulin-treated type 2 diabetes (ONWARDS 2): a phase 3a, randomised, open label, multicentre, treat-to-target
Philis-Tsimikas A, Asong M, Franek E, et al.
Lancet Diabetes Endocrinol. 2023;S2213-8587(23)00093-1.
Leggi
Association between brachial-ankle pulse wave velocity and microvascular complications in type 2 diabetes mellitus
Pei Y, Shu Y, Deng B , Liu Y
BMC Endocr Disord. 2023;23(1):98.
Leggi
Vitamin K2 supplementation improves impaired glycemic homeostasis and insulin sensitivity for type 2 diabetes through gut microbiome and fecal metabolites
Zhang Y, Liu L, Wei C, et al.
BMC Med. 2023;21(1):174.
Leggi